InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+13.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Frazier Life Sciences VIII, L.P.. Director active across 3 companies, notably Arcutis Biotherapeutics, Inc.. Aggregated, 7 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €5.8m. History available since 10 May 2021. The latest transaction was disclosed on 24 October 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
80,000 shares@ US$2.503.7% of flowCommon StockSEC:0001209191-23-053662:0
Ideal exit: 20 Jul 2024 (T+270)
250,000 shares@ US$20.0096.3% of flowCommon StockSEC:0001209191-22-045014:0
Ideal exit: 2 May 2023 (T+270)
112,665 shares@ US$7.1006100.0% of flowCommon StockSEC:0001209191-22-009821:0
Ideal exit: 8 Nov 2022 (T+270)
1,200,000 sharesCommon StockSEC:0001209191-21-057010:0
1,200,000 sharesCommon StockSEC:0001209191-21-057010
2,108,558 shares0Common StockSEC:0001209191-21-032151:0
2,108,558 shares0Common StockSEC:0001209191-21-032151
7 of 7 declarations
About Frazier Life Sciences VIII, L.P.
Frazier Life Sciences VIII, L.P. is a director and insider at Arcutis Biotherapeutics, Inc. and ALPINE IMMUNE SCIENCES, INC.
